- Exchanges
- BSE, NSE
- Industry
- Personal Care
- Issue
- Book building
JHS Svendgaard Laboratories IPO
₹56.95
−1.81% on listing
Listing-day close · NSE · 21 Oct 2006 · issue price ₹58
JHS Svendgaard Laboratories’ ₹38.86 crore IPO was priced at ₹58 a share. It listed on the NSE on 21 Oct 2006 and closed its first day at ₹56.95, down 1.81% on the issue price.
Timeline
- Opens
- Closes
- Listing
Issue details
- Issue size
- ₹38.86 Cr
- Fresh issue
- ₹38.86 Cr
- Offer for sale
- —
- Lot size
- 120 shares
- Minimum investment
- ₹6,960
- Face value
- ₹10
- Registrar
- MUFG Intime India
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 2.61× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹72.50 Cr
- Promoter holding
- 97.71% → 49.35%
Financials as of 31 Mar 2006, from the offer documents.
Listing
- Listing date
- 21 Oct 2006
- Issue price
- ₹58
- Open
- ₹95.00
- High
- ₹95.00
- Low
- ₹55.00
- Close
- ₹56.95
Listing day on the NSE. The close was −1.81% on the issue price.
JHS share price todayFAQs
When did the JHS Svendgaard Laboratories IPO open and close?
It opened on 26 Sep 2006 and closed on 4 Oct 2006.
What was the JHS Svendgaard Laboratories IPO price?
The price band was ₹49–58 a share. The final issue price was ₹58.
What is the lot size and minimum investment?
One lot is 120 shares, ₹6,960 at ₹58 a share. Retail investors apply in whole lots.
How much did JHS Svendgaard Laboratories raise?
₹38.86 crore: ₹38.86 crore of new shares.
How many times was the JHS Svendgaard Laboratories IPO subscribed?
2.61 times overall.
How did JHS Svendgaard Laboratories list?
It listed on the NSE on 21 Oct 2006 at ₹95.00 and closed the day at ₹56.95, down 1.81% on the ₹58 issue price.
Who is the registrar of the JHS Svendgaard Laboratories IPO?
MUFG Intime India handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app